Mark A. Schlossberg
General Counsel, Impax Laboratories, LLC.
Companies
- CytokineticsGeneral counsel Jan 22, 2019 to Mar 15, 20221
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Cytokinetics CYTK103,408 shares2$6.4M at $61.95Mar 15, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 15, 2022Sold 25,196 shares at $33.96 of Cytokinetics2
- Mar 15, 2022Exercised options 25,196 shares at $14.40 of Cytokinetics2
- Mar 15, 2022Exercised options 4,803 shares at $14.40 of Cytokinetics2
- Mar 15, 2022Exercised options 30,818 shares at $7.03 of Cytokinetics2
- Mar 7, 2022Shares withheld for tax 4,631 shares at $36.83 of Cytokinetics3
- Mar 2, 2022Granted 20,000 shares of Cytokinetics4
- Mar 2, 2022Shares withheld for tax 3,457 shares at $37.63 of Cytokinetics4
- Feb 16, 2022Granted 3,125 shares of Cytokinetics5
- Feb 16, 2022Granted 1,900 shares of Cytokinetics5
- Oct 19, 2021Sold 19,979 shares at $35.74 of Cytokinetics6
- Oct 19, 2021Exercised options 19,979 shares at $7.03 of Cytokinetics6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCytokinetics, General counsel
- 2
- 3SEC EDGARForm 4 filed Mar 8, 2022
- 4SEC EDGARForm 4 filed Mar 3, 2022
- 5SEC EDGARForm 4 filed Feb 17, 2022
- 6SEC EDGARForm 4 filed Oct 20, 2021